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introduction: The IMPACT registry captures data on cardiac catheterizations in patients with congenital heart disease. Since inception in January 
2011, IMPACT participation has increased to 65 congenital heart centers which have submitted 8889 reports of catheterization. These reports 
include data specific to stent implantation for treatment of Coarctation of the Aorta (CoA) and for treatment of Proximal Pulmonary Artery Stenosis 
(PA).
methods: From July 2011 until June 2012, 6834 catheterizations met IMPACT Data Quality Guidelines. Among these, reports of CoA and PA 
Stenting were reviewed including hemodynamic data, procedural characteristics, and adverse events (AE).
results: There were 87 (1.3%) cath lab visits for CoA stenting; median length of stay (LOS) 1.0 day. Indications: gradient (43.7%), hypertension 
(32.2%), LV dysfunction (12.6%), appearance (10.3%). Pre-procedure: median gradient was 28 mmHg. CoA stent implanted in 97.9%. Post 
procedure: residual gradient: 20 in 2.9%. AEs included bleeding or other events requiring transfusion in 8 (9.3%), arrhythmia requiring medication in 
2. Planned cardiac surgery performed in 4 (4.7%) patients; unplanned cardiac surgery in 1.
There were 87 (1.3%) cath lab visits for PA stenting; LOS 1 day. Indications: gradient (31.0%), RV hypertension/dysfunction (16.1%), PA flow 
discrepancy (24.1%), appearance (25.3%). Pre-procedure: RV/LV 0.6. PA stent implanted in 100%: LPA (71.4%), RPA (28.6%). Side branch jailing 
occurred in 7 (7.2%), and was intended in 6. AEs included arrhythmia in 3 (3.5%), requiring medication 1, cardioversion 1; bleeding or other events 
requiring transfusion 5 (5.8%); cardiac arrest 2. Planned cardiac surgery performed in 1 patient; unplanned in none.
conclusions: Reported success rates of CoA and PA stenting are high and complication rates are low. No catastrophic vessel ruptures were 
reported, and there were no deaths.
